R
eturn of spontaneous circulation (ROSC) is just the first challenge when a person has a cardiac arrest. At least equally important from a patient perspective are survival to hospital discharge and a good neurological outcome. The 2015 update to the American Heart Association guidelines 1 emphasizes the importance in postcardiac arrest care of identification and treatment of the cause of the cardiac arrest and assessment and mitigation of ischemia-reperfusion injury to multiple organs including the brain. The associated systematic review identified 3 observational studies suggesting that hyperoxia may worsen patient outcomes, although 6 other studies, including 1 small randomized controlled trial, 2 did not confirm this finding. 1 The guideline recommendation is to use the highest possible available oxygen concentration until the arterial oxygen saturation estimated by pulse oximetry (Spo 2 ) or Pao 2 can be measured (class IIa, level of evidence C, expert opinion). When these measurements are available, an oxyhemoglobin saturation >94% is recommended.
The theoretical basis for avoiding hyperoxia when an ischemia-reperfusion injury is present is strong. Production of reactive oxygen species by mitochondria generally increases with increasing oxygen tension leading to oxidative stress and flow on effects that include damage to nucleic acids, proteins, and lipids; cell death through both apoptotic and necrotic pathways; release of endogenous damageassociated molecular pattern molecules with subsequent mitochondrial damage; and polymorph activation with a systemic inflammatory response. 3 Hyperoxia can also induce adverse cardiovascular effects that include reduced coronary blood flow of 8% to 29% in various settings, vasoconstriction, and increased heterogeneity within the microcirculation that reduces oxygen delivery to underperfused tissue. 4 A meta-analysis of animal studies modeling cardiac arrest and subsequent cardiopulmonary resuscitation comparing ventilation with 100% oxygen with ventilation with a lower oxygen concentration included 6 studies, and found a significantly worse neurological deficit score in the animals ventilated with 100% oxygen. 5 In 4 of the 5 studies that included postmortem histological examination of the brain, there was also evidence of increased neuronal damage. 5 In this issue of Circulation, Roberts and colleagues 6 report a prospective multicenter protocol-directed cohort study examining the association between early hyperoxia after cardiac arrest and neurological disability. They found that early hyperoxia was independently associated with poor neurological function as assessed using the modified Rankin scale (at hospital discharge). In addition to their standard definition of hyperoxia as a Pao 2 >300 mm Hg in the first 6 hours after ROSC, they examined the association of Pao 2 between 100 and 400 mm Hg during this 6-hour period with neurological outcome, finding that the association with poor outcome only occurred at ≥300 mm Hg. This is an important finding because, although hyperoxia has commonly been defined as >300 mm Hg, 7 it has had no investigational basis. Kilgannon and colleagues, 8 for example, specify that the choice of a cutoff of 300 mm Hg to define hyperoxia in their observational study was based on a consensus of all authors and nothing more.
A meta-analysis of human observational studies 7 of the association between hyperoxia after cardiac arrest and patient outcomes found an association between hyperoxia and increased hospital mortality (odds ratio, 1.4; 95% confidence interval, 1.02-1.93) over 8 studies, but neurological outcome was only assessed in 2 studies with inconclusive results (odds ratio, 1.62; 95% confidence interval, 0.87-3.02). The authors advise caution in the interpretation of their results because of the few studies included and significant heterogeneity between studies. Although the studies generally scored well on the Newcastle-Ottawa scale for assessment of observational studies, 9 an important limitation was the variation in the timing of the Pao 2 value used in their analysis with 5 of the 10 studies using first Pao 2 , 3 the highest Pao 2 and 3 the worst Pao 2 based on Pao 2 /fraction of inspired oxygen (Fio 2 ) ratio. As with all observational studies, there was also the potential for unmeasured confounders to bias the outcome. For example, healthcare workers may have had a tendency to provide more oxygen to patients doing poorly in the hope of assisting them. Also, 6 of the studies analyzed multicenter databases (Project IMPACT and ANZICS-APD [Australian and New Zealand Intensive Care Society Adult Patient Database]) with some overlap between cohorts and the uncertainties of data accuracy associated with registry information.
The study by Roberts et al 6 sought to overcome any effect from variation in sampling times by a protocol that specified sampling at 1 and 6 hours after ROSC. Thirtyeight percent of their patients were exposed to hyperoxia. The strengths of the study facilitated by the prospective design were standardized elements of postcardiac arrest care across all sites, detailed data collection and assimilation into an electronic research database, sophisticated data analysis, and reporting in accordance with the STROBE statement (Strengthening the Reporting of Observational Studies in Epidemiology). 10 The authors correctly identify the limitations of observational studies in determining cause and effect and the potential for unmeasured confounders. It is also important to note that they included patients with both out-of-hospital and in-hospital cardiac arrests, and that, although 280 patients were included, this was from 2084 screened for inclusion with 326 excluded because of lack of informed consent.
The authors also draw attention (see their online-only Data Supplement) to the discordance between measured Pao 2 and corresponding Spo 2 . Large differences between Spo 2 and Sao 2 have been shown in critically ill patients, 11 but surprisingly little information exists on the relationship between these measurements after cardiac arrest. A lack of reliability of Spo 2 in this setting has important implications for the design of future studies. Although it is made easier and quicker to apply a Spo 2 monitor than obtain arterial blood gas samples, Spo 2 monitoring has limitations in low-flow states.
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The cardiac output is low during resuscitation for a cardiac arrest 12 and often remains low after ROSC. The consequent low mixed venous oxygen saturation exacerbates hypoxemia caused by ventilation-perfusion mismatching as blood passes through the lungs, and this is relatively resistant to ventilation using high oxygen concentrations. Cerebral oximetry could provide an alternative means of monitoring the adequacy of oxygen delivery to the brain and appears feasible in the context of cardiac arrest research but of uncertain benefit. 12 It is possible that the effect of hyperoxia actually during cardiopulmonary resuscitation differs from that after ROSC when the mitigation of postcardiac arrest syndrome becomes the priority. In a retrospective study of patients with out-of-hospital cardiac arrest treated by a physician-staffed emergency medical service, 13 the rates of hospital admission were 19% for those with a measured Pao 2 ≤60 mm Hg during cardiopulmonary resuscitation, 51% for those 61 to 300 mm Hg, and 84% for those >300 mm Hg. However, the sample size was relatively small (145 patients), and it is possible that the measured Pao 2 reflected the effectiveness of cardiopulmonary resuscitation and, hence, an association with hospital admission rates.
So where to from here? Randomized clinical trials will not be easy. There will be those who will lack the equipoise required for participation in a randomized clinical trial based on the experimental studies and limited, largely observational, human studies. In some jurisdictions, human research ethics committees may permit studies of different oxygenation strategies during and after cardiac arrest based on a waiver of consent, but, after ROSC, more are likely to require consent from a legally recognized surrogate. The logistics of conducting a time-critical study in a population with randomly occurring life-threatening events will also be challenging.
A small randomized comparison of ventilation with 30% and 100% oxygen after ROSC 2 that included 32 patients suggested that this was a safe strategy, although the Fio 2 had to be increased in 5 of 14 patients to maintain a Spo 2 ≥95%. However, another small feasibility study 14 comparing hyperoxic with normoxic therapy in patients with ROSC after out-of-hospital cardiac arrest caused by ventricular fibrillation or ventricular tachycardia randomly assigned 18 patients from 159 screened and was able to analyze results from 17. In the titrated oxygen therapy group, 7 of the 8 had low measured Spo 2 (<88%) during the prehospital pe- riod, leading the authors to conclude that prehospital oxygen titration was not safely feasible. However, titration in hospital did appear feasible, and there was good separation of Spo 2 and Pao 2 between groups.
The EXACT study (Reduction of Oxygen After Cardiac Arrest) is a phase 3 multicenter randomized trial comparing reduced oxygen administration targeting low-normal arterial oxygen saturations (90%-94%) as soon as possible after hospital admission, with the current practice of continuing 100% oxygen administration. 15 The primary end point is survival to hospital discharge after out-of-hospital cardiac arrest. When completed, it should provide higher-quality evidence on the effect of hyperoxia on patient survival and hopefully also on neurological outcomes. It should also provide further information on the reliability of Spo 2 measurements in avoiding hyperoxia in this patient population. The remaining research question will be whether avoiding hyperoxia immediately after ROSC, but before hospital admission in out-of-hospital cardiac arrest, impacts patient survival or neurological recovery.
The current American Heart Association guidelines 1 remain supported by the best available evidence. An oxygenation strategy of maintaining the oxyhemoglobin saturation in the range 94% to 99% after ROSC and downtitrating the inspired oxygen while the saturation remains 100% appears appropriate: enough is enough. Whenever possible, though, titration of Fio 2 should be based on an arterial blood gas analysis rather than Spo 2 measurements that may be spurious.
